{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:06:56Z","timestamp":1789369616540,"version":"build-2803163510"},"reference-count":93,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T00:00:00Z","timestamp":1073865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We analysed the nature and prognostic significance of secondary cytogenetic changes in 111 newly diagnosed adults with acute lymphoblastic leukaemia (ALL) and t(9;22)(q34;q11.2) or its variants. Secondary aberrations were seen in 75 (68%) patients. They included, in order of descending frequency: +der(22)t(9;22), +21, abnormalities of 9p, high hyperdiploidy (&gt;50 chromosomes), +8, \u22127, +X and abnormalities resulting in loss of material from 8p, gain of 8q, gain of 1q and loss of 7p. Eighty patients (72%) had \u22651 normal metaphase in their karyotype. There were four balanced and 12 unbalanced translocations previously unreported in ALL with t(9;22). The t(2;7)(p11;p13) and der(18)t(8;18)(q11.2;p11.2) were seen in two cases each, and have never before been reported in haematological malignancy. All but four patients were treated on front\u2010line Cancer and Leukaemia Group\u00a0B clinical protocols. The presence of \u22127 as a sole secondary abnormality was associated with a lower complete remission (CR) rate (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7004), while the presence of \u22653 aberrations was associated with a higher CR rate (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7009) and +der(22)t(9;22) with a higher cumulative incidence of relapse (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b702). It will be of interest to see if newly diagnosed t(9;22)\u2010positive adult ALL patients with these and other secondary aberrations respond differently to treatment regimens that include imatinib mesylate.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04736.x","type":"journal-article","created":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T08:29:43Z","timestamp":1073896183000},"page":"275-288","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Additional cytogenetic abnormalities in adults with Philadelphia chromosome\u2010positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group\u00a0B"],"prefix":"10.1111","volume":"124","author":[{"given":"Meir","family":"Wetzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Mr\u00f3zek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleton C.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramana","family":"Tantravahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Vardiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara D.","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,1,12]]},"reference":[{"key":"e_1_2_18_2_1","first-page":"9","article-title":"Chromosomal pattern in acute lymphoblastic leukaemia","volume":"40","author":"Abdi S.I.A.","year":"1990","journal-title":"Journal of the Pakistan Medical Association"},{"key":"e_1_2_18_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860915)58:6<1260::AID-CNCR2820580614>3.0.CO;2-O"},{"key":"e_1_2_18_4_1","volume-title":"Categorical Data Analysis","author":"Agresti A.","year":"1990"},{"key":"e_1_2_18_5_1","first-page":"795","article-title":"Lineage involvement by BCR\/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia","volume":"10","author":"Anastasi J.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_18_6_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90190.x"},{"key":"e_1_2_18_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02684.x"},{"key":"e_1_2_18_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(89)90023-X"},{"key":"e_1_2_18_9_1","first-page":"813","article-title":"Long\u2010term survival and proliferation of precursor\u2010B acute lymphoblastic leukemia cells on human bone marrow stroma","volume":"10","author":"Bradstock K.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_18_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0772"},{"key":"e_1_2_18_11_1","first-page":"888","article-title":"Karyotype refinement by multicolor fluorescence in situ hybridization analysis in 18 patients with acute lymphoblastic leukemia","volume":"87","author":"Calabrese G.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_18_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.309"},{"key":"e_1_2_18_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01714978"},{"key":"e_1_2_18_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90255-7"},{"key":"e_1_2_18_15_1","first-page":"261","article-title":"Philadelphia positive acute leukemia: lineage promiscuity and inconsistently rearranged breakpoint cluster region","volume":"2","author":"Chen S.J.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_18_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198508013130503"},{"key":"e_1_2_18_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.3.489.489"},{"key":"e_1_2_18_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08306.x"},{"key":"e_1_2_18_19_1","first-page":"425","article-title":"Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study","volume":"5","author":"Cuttner J.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_18_20_1","first-page":"3931","article-title":"Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group\u00a0B study 8364","volume":"93","author":"Czuczman M.S.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_18_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401430"},{"key":"e_1_2_18_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700964"},{"key":"e_1_2_18_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320370750"},{"key":"e_1_2_18_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(02)00599-X"},{"key":"e_1_2_18_25_1","first-page":"365","article-title":"Bone marrow transplantation for Philadelphia chromosome\u2010positive acute lymphoblastic leukemia","volume":"17","author":"Dunlop L.C.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_18_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400637"},{"key":"e_1_2_18_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.11.2002"},{"key":"e_1_2_18_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(87)90114-7"},{"key":"e_1_2_18_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009148847"},{"key":"e_1_2_18_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900070409"},{"key":"e_1_2_18_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.3.435.435"},{"key":"e_1_2_18_32_1","first-page":"1318","article-title":"Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)","volume":"8","author":"Fonatsch C.","year":"1994","journal-title":"Leukemia"},{"issue":"1","key":"e_1_2_18_33_1","first-page":"334a","article-title":"Toxicity and pharmacokinetics of PEG\u2010asparaginase (PEG\u2010asn) in newly diagnosed adult acute lymphoblastic leukemia (ALL): CALGB 9511","volume":"90","author":"Frankel S.R.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_18_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(97)00119-7"},{"key":"e_1_2_18_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062538"},{"key":"e_1_2_18_36_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951"},{"key":"e_1_2_18_37_1","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"87","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","year":"1996","journal-title":"Blood"},{"key":"e_1_2_18_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00282-996-0177-7"},{"key":"e_1_2_18_39_1","first-page":"185","article-title":"Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia","volume":"6","author":"Heerema N.A.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_18_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(91)90139-L"},{"key":"e_1_2_18_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402741"},{"key":"e_1_2_18_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.1103"},{"key":"e_1_2_18_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_18_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10227"},{"key":"e_1_2_18_45_1","first-page":"547","article-title":"Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization","volume":"82","author":"Kobayashi H.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_18_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-5223.1985.tb00484.x"},{"key":"e_1_2_18_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.00055.x"},{"key":"e_1_2_18_48_1","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five\u2010drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group\u00a0B study 8811","volume":"85","author":"Larson R.A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_18_49_1","first-page":"1556","article-title":"A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB Study 9111","volume":"92","author":"Larson R.A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_18_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(83)90046-2"},{"key":"e_1_2_18_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(98)00058-2"},{"key":"e_1_2_18_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3479"},{"key":"e_1_2_18_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(89)90159-3"},{"key":"e_1_2_18_54_1","volume-title":"ISCN (1995): An International System for Human Cytogenetic Nomenclature","author":"Mitelman F.","year":"1995"},{"key":"e_1_2_18_55_1","unstructured":"Mitelman F. Johansson B.&Mertens F.(eds) (2003) Mitelman database of chromosome aberrations in cancer 5\/2003 update. WWW document. Available athttp:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman."},{"key":"e_1_2_18_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)90189-9"},{"key":"e_1_2_18_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/B0-12-227555-1\/00505-0"},{"key":"e_1_2_18_58_1","first-page":"531","article-title":"Der(16)t(1;16) is a nonrandom secondary chromosome aberration in many types of human neoplasia, including myxoid liposarcoma, rhabdomyosarcoma and Philadelphia chromosome\u2010positive acute lymphoblastic leukemia","volume":"6","author":"Mr\u00f3zek K.","year":"1995","journal-title":"International Journal of Oncology"},{"key":"e_1_2_18_59_1","first-page":"485","article-title":"New chromosomal breakpoints in non\u2010Hodgkin's lymphomas revealed by spectral karyotyping and G\u2010banding","volume":"5","author":"Nordgren A.","year":"2000","journal-title":"International Journal of Molecular Medicine"},{"key":"e_1_2_18_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050175"},{"key":"e_1_2_18_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0777"},{"key":"e_1_2_18_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(84)90026-8"},{"key":"e_1_2_18_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870040402"},{"key":"e_1_2_18_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_18_65_1","first-page":"541","article-title":"Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders","volume":"1","author":"Pollak C.","year":"1987","journal-title":"Leukemia"},{"key":"e_1_2_18_66_1","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1182\/blood.V81.10.2696.2696","article-title":"DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18","volume":"81","author":"Porfiri E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_18_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90049-3"},{"key":"e_1_2_18_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019606-200012000-00002"},{"key":"e_1_2_18_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.8.1380"},{"key":"e_1_2_18_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010501)91:9<1704::AID-CNCR1187>3.0.CO;2-D"},{"key":"e_1_2_18_71_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1968.x"},{"key":"e_1_2_18_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.5.1050.1050"},{"key":"e_1_2_18_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400986"},{"key":"e_1_2_18_74_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x"},{"key":"e_1_2_18_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90187-7"},{"key":"e_1_2_18_76_1","first-page":"37","article-title":"Nonparametric confidence limits for survival probabilities and median survival time","volume":"66","author":"Simon R.","year":"1982","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_18_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401589"},{"key":"e_1_2_18_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704303161802"},{"key":"e_1_2_18_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920315)69:6 <1543::AID-CNCR2820691307>3.0.CO;2-O"},{"key":"e_1_2_18_80_1","first-page":"590a","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): phase II trial of dose intensification of daunorubicin and cytarabine followed by high\u2010dose methotrexate and intrathecal methotrexate in place of cranial irradiation (CALGB 19802)","volume":"98","author":"Stock W.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_18_81_1","first-page":"663","article-title":"Bone marrow transplantation for Philadelphia\u2010chromosome\u2010positive acute lymphoblastic leukemia","volume":"16","author":"Stockschlader M.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_18_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.2.324.324"},{"key":"e_1_2_18_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11219"},{"key":"e_1_2_18_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(81)90025-X"},{"key":"e_1_2_18_85_1","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.V84.7.2283.2283","article-title":"Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia","volume":"84","author":"Taniwaki M.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_18_86_1","first-page":"430","article-title":"Chromosomal alterations in acute leukemia patients studied with improved culture methods","volume":"45","author":"Testa J.R.","year":"1985","journal-title":"Cancer Research"},{"key":"e_1_2_18_87_1","first-page":"119","article-title":"Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome","volume":"40","author":"Thomas X.","year":"1998","journal-title":"Hematology and Cell Therapy"},{"key":"e_1_2_18_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.527"},{"key":"e_1_2_18_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2030::AID-CNCR21>3.0.CO;2-Q"},{"key":"e_1_2_18_90_1","doi-asserted-by":"crossref","unstructured":"United Kingdom Cancer Cytogenetics Group(1992)Translocations involving 9p and\/or 12p in acute lymphoblastic leukemia.Genes Chromosomes & Cancer 5 255\u2013259.","DOI":"10.1002\/gcc.2870050314"},{"key":"e_1_2_18_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90175-D"},{"key":"e_1_2_18_92_1","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V80.12.2983.2983","article-title":"Clinical significance of the BCR\u2010ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group\u00a0B Study (8762)","volume":"80","author":"Westbrook C.A.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_18_93_1","first-page":"3983","article-title":"Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group\u00a0B experience","volume":"93","author":"Wetzler M.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_18_94_1","first-page":"355","article-title":"Ph1\u2010positive acute leukemia in a patient with Hodgkin's disease treated by irradiation and chemotherapy","volume":"33","author":"Yavorkovsky L.L.","year":"1986","journal-title":"Neoplasma"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04736.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04736.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04736.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:23:01Z","timestamp":1697394181000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04736.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,12]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04736.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04736.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,12]]},"assertion":[{"value":"2004-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}